It was reported to philips that the device shock not delivery 3 times when using on a patient.The device was reported to be in use on a patient, causing a delay in therapy/treatment and will be considered a serious injury.However, no direct adverse event to the patient or user was reported.
|
The efficia dfm100 defibrillator, model# 866199, is substantially similar to the heartstart xl+ defibrillator (model # 861290) and will be reported in the united states under device model # 861290.It was reported to philips that the device shock not delivery 3 times when using on a patient.The device was reported to be in use on a patient, causing a delay in therapy/treatment and will be considered a serious injury.However, no direct adverse event to the patient or user was reported.This reporter stated that a patient of unknown age, gender, and weight was admitted to a hospital on an unknown date with the admitting diagnosis not reported.No relevant medical history, relevant past drug history or relevant concomitant medical products were reported.It was reported to philips that the alleged failure was observed while the device was in use on a patient on (b)(6) 2020.However, no adverse patient impact was reported.The customer requested that a philips field service engineer (fse) be dispatched to the customer site.The reported issue was confirmed and traced to a faulty processor pca.The processor pca was replaced and applied sw software version rev.2.00.23, the device passed all performance assurance testing.The device remains at the customer site and no further evaluation is required at this time.As there is minimal health risk associated with this event, no further investigation or action is warranted at this time.
|
Submission of a report does not constitute an admission that medical personnel, user facility, importer, distributor, manufacturer, or product caused or contributed to the event.
|